Your browser doesn't support javascript.
loading
Factors associated with prompt recovery among hospitalised patients with coronavirus disease 2019.
Ny, Pamela; Kelsom, Corey; Chron, Amanda; Lou, Mimi; Nieberg, Paul; Shriner, Kimberly; Huse, Holly; Wong-Beringer, Annie.
Afiliação
  • Ny P; Huntington Hospital, Pasadena, California, USA.
  • Kelsom C; Huntington Hospital, Pasadena, California, USA.
  • Chron A; University of Southern California, Los Angeles, California, USA.
  • Lou M; University of Southern California, Los Angeles, California, USA.
  • Nieberg P; University of Southern California, Los Angeles, California, USA.
  • Shriner K; Huntington Hospital, Pasadena, California, USA.
  • Huse H; Huntington Hospital, Pasadena, California, USA.
  • Wong-Beringer A; Huntington Hospital, Pasadena, California, USA.
Int J Clin Pract ; 75(11): e14818, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34487380
BACKGROUND: Patients who survived hospitalisation for COVID-19 experienced varying durations of illness but the factors associated with prompt recovery are unknown. This study identifies factors differentiating hospitalised patients who recovered promptly versus survived a prolonged course of illness because of COVID-19. METHODS: This was a retrospective study from March-August 2020 of hospitalised adults with COVID-19 which were grouped based on time to recovery: short (≤3 days), intermediate (4-10 days) and prolonged (>10 days). Recovery was defined as resolution of fever, tachypnea, hypotension, extubation and return of mental status at baseline. Multivariate analysis was used to evaluate factors associated with prompt recovery. RESULTS: Among 508 patients hospitalised for COVID-19, 401 (79%) survived. Of those, prompt recovery (within 3 days) was achieved in 43% (174/401), whereas 23% (92/401) recovered after a prolonged period of >10 days. Overall, median age was 64 years with 73% admitted from home and 25% from a skilled nursing facility. Predictors for prompt recovery upon admission included female sex (OR, 1.8; 95% CI, 1.1-2.7; P = .01), no fever (OR, 1.6; 95% CI, 1.1-2.6; P = .03), longer time from symptom onset to hospitalisation (OR, 1.1; 95% CI, 1.0-1.1; P = .001), no supplemental oxygen (OR, 1.9; 95% CI, 1.2-3.0; P = .004), no direct ICU admission (OR, 41.7; 95% CI, 2.4-740.4; P = .01) and absence of bacterial co-infections (OR, 2.5; 95% CI, 1.5-4.0, P = .0003). CONCLUSIONS: Our study provides relevant data that could help clinicians triage competing resources in health systems that are challenged by the ebb and flow of COVID-19 cases by identifying clinical features of COVID-19 patients who may require less intensive management including avoidance of unnecessary antibacterial therapy.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Int J Clin Pract Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Int J Clin Pract Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos